Resumption of oral anticoagulation after spontaneous intracerebral hemorrhage.

Jochen A SembillJoji B KuramatsuStefan SchwabHagen B Huttner

Published in: Neurological research and practice (2019)

According to observational data OAC resumption after ICH seems beneficial and safe. Ongoing clinical trials will create evidence regarding treatment effects of pharmaceutical resumption and interventional alternatives. Yet, individual decision making weighing the patient's individual thromboembolic versus hemorrhagic risks remains essential.

Keyphrases

clinical trial
decision making
atrial fibrillation
brain injury
case report
venous thromboembolism
electronic health record
human health
cross sectional
randomized controlled trial
risk assessment
phase ii
machine learning
combination therapy
open label
phase iii
artificial intelligence
study protocol